Inhibikase Therapeutics, Inc. (IKT)

Inhibikase Therapeutics Employees

As of December 31, 2024, Inhibikase Therapeutics had 16 total employees, including 15 full-time and 1 part-time employees. The number of employees increased by 7 or 77.78% compared to the previous year.

• Employees: 16
• Change (1Y): 7
• Growth (1Y): 77.78%
• Revenue / Employee: n/a
• Profits / Employee: -$2,284,312
• Market Cap: 120.43M

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	16	7	77.78%
Dec 31, 2023	9	2	28.57%
Dec 31, 2022	7	0	-
Dec 31, 2021	7	4	133.33%
Dec 31, 2020	3	-	-